Iris Diseases: Clinical Trials

2 trials for Iris Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Not yet recruiting 2

Follow Iris Diseases: new trials by email Literature Review of Iris Diseases trials Research Report on Iris Diseases

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients
tamsulosin 0.4mg, Silodosin 8 mg - Benign Prostatic Hyperplasia, Silodosin
Phase 4Not yet recruitingMohsen Pourazizi402026-08-012026-08-03
Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients
tamsulosin 0.4mg, Silodosin 8 mg - Benign Prostatic Hyperplasia, Tamsulosin
Phase 4Not yet recruitingMohsen Pourazizi402026-08-012026-08-03

Narrower conditions

Prostatic Hyperplasia (2)

Broader conditions

Eye Diseases (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Male Urogenital Diseases (2)  ·  Prostatic Diseases (2)  ·  Urogenital Diseases (2)  ·  Uveal Diseases (2)

Interventions

Tamsulosin (2)  ·  silodosin (2)

Sponsors

Mohsen Pourazizi (2)

Top investigators

Mohsen Pourazizi (1)  ·  Mohsen Pourazizi, Assistant Professor (1)